West Pharma (WST) Tops Q1 EPS by 22c, provides guidance
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $342.35 +1.09%
Revenue Growth %: +2.5%
Financial Fact:
Research and development: 9M
Today's EPS Names:
RCBC, GASS, YSG, More
Revenue Growth %: +2.5%
Financial Fact:
Research and development: 9M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q1 EPS of $1.45, $0.22 better than the analyst estimate of $1.23. Revenue for the quarter came in at $698 million versus the consensus estimate of $684.94 million.
GUIDANCE:
West Pharma sees FY2025 EPS of $6.15-$6.35, versus the consensus of $7.02. West Pharma sees FY2025 revenue of $2.945-2.975 billion, versus the consensus of $3.093 billion.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Ollie's Bargain Outlet (OLLI) Tops Q2 EPS by 28c, Offers Guidance
- Wilton Resources closes $565,000 private placement financing
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
